KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Working Capital Changes (2020 - 2025)

Aurinia Pharmaceuticals' Other Working Capital Changes history spans 6 years, with the latest figure at $138000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 110.85% year-over-year to $138000.0; the TTM value through Dec 2025 reached -$802000.0, down 6.93%, while the annual FY2025 figure was -$802000.0, 6.93% down from the prior year.
  • Other Working Capital Changes reached $138000.0 in Q4 2025 per AUPH's latest filing, up from -$545000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $5.6 million in Q2 2025 to a low of -$6.5 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is $77950.0, with a median of -$102000.0 recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: skyrocketed 294.23% in 2024, then crashed 201000.0% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$6.5 million in 2021, then skyrocketed by 37.12% to -$4.1 million in 2022, then surged by 203.62% to $4.3 million in 2023, then tumbled by 129.85% to -$1.3 million in 2024, then soared by 110.85% to $138000.0 in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Other Working Capital Changes are $138000.0 (Q4 2025), -$545000.0 (Q3 2025), and $5.6 million (Q2 2025).